Clinicopathologic characteristics of pancreatic islet amyloidosis in the rhesus macaque (Macaca mulatta) and sooty mangabey (Cercocebus atys). Issue 3 (31st March 2022)

• Record Type: Journal Article
• Authors: Birdwell, Leeza; Levesque, Denyse; Machiah, Deepa; Gumber, Sanjeev
• Is Part Of: Journal of medical primatology. Volume 51:Issue 3(2022)
• Page Start: 155
• Page End: 164
• Publication Date: 2022-03-31
• Subjects: diabetes mellitus -- fructosamine -- glucagon -- glucosuria -- human islet amyloid polypeptide -- hyperglycemia -- immunohistochemistry -- insulin -- pancreatic islet amyloid -- serum amyloid P; Primates -- Periodicals; Primates -- Diseases -- Periodicals; Medicine, Experimental -- Periodicals; 616.02738
• DOI: 10.1111/jmp.12579
• Languages: English
• ISSNs: 0047-2565

Abstract

Abstract: Background: Diabetes mellitus type 2 has been linked to pancreatic islet amyloid deposition in humans and nonhuman primates. The authors hypothesized that diabetic primates would have significant differences in pathology than non‐diabetic groups. Methods: This retrospective study used histopathology and immunohistochemistry to characterize and compare pancreatic islet amyloidosis in 58 diabetic and non‐diabetic rhesus macaque (RM) and sooty mangabeys (SM). Results: The pancreatic tissues from diabetic RM and SM showed higher histopathology scores for islet amyloid deposit distribution, severity, and calcification deposits compared to their respective non‐diabetic cohorts. Further, these tissues from RM and SM with amyloid deposits showed immunoreactivity to insulin, glucagon, islet amyloid polypeptide, serum amyloid P, and glucagon‐like peptide 1. Conclusions: Histopathology results showed that the defined amyloid characteristics are associated with clinical diabetes in both species. The immunohistochemistry results collectively suggest differences in pancreatic hormones and islet amyloid components among both species and diabetic status.